Janus Henderson Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Janus Henderson Group’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,701	Closed	-$254K	–	2642
2023 Q3	$254K	Buy	13,701 +2	+0%	+$23	﹤0.01%	2267
2023 Q2	$151K	Sell	13,699 -21	-0.2%	-$293	﹤0.01%	2515
2023 Q1	$184K	Buy	+13,720	New	+$237K	﹤0.01%	2514
2015 Q2	–	Sell	-25,000	Closed	-$7.05M	–	884
2015 Q1	$7.05M	Buy	+25,000	New	+$5.41M	0.05%	325

Janus Henderson Group's ICPT Position: Q4 2023 in Review

Janus Henderson Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 13,701 shares — an estimated $254K sold.

Janus Henderson Group first reported a position in ICPT in Q1 2015 and held it in 4 quarters. The position peaked at $7.05M in Q1 2015. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Janus Henderson Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Janus Henderson Group sold 13,701 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $254K.
Janus Henderson Group first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 4 quarters.
Janus Henderson Group's Intercept Pharmaceuticals, Inc. position peaked at $7.05M in Q1 2015.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.